{"title": "Naltrexone implant helps HIV patients with opioid dependence prevent relapse", "title_detail": {"type": "text/plain", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/pharmaceuticals.xml", "value": "Naltrexone implant helps HIV patients with opioid dependence prevent relapse"}, "links": [{"rel": "alternate", "type": "text/html", "href": "https://www.sciencedaily.com/releases/2019/03/190321130327.htm"}], "link": "https://www.sciencedaily.com/releases/2019/03/190321130327.htm", "summary": "A new study shows that a naltrexone implant placed under the skin was more effective at helping HIV-positive patients with an opioid addiction reduce relapse and have better HIV-related outcomes compared to the oral drug.", "summary_detail": {"type": "text/html", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/pharmaceuticals.xml", "value": "A new study shows that a naltrexone implant placed under the skin was more effective at helping HIV-positive patients with an opioid addiction reduce relapse and have better HIV-related outcomes compared to the oral drug."}, "published": "Thu, 21 Mar 2019 13:03:27 EDT", "published_parsed": [2019, 3, 21, 17, 3, 27, 3, 80, 0], "id": "https://www.sciencedaily.com/releases/2019/03/190321130327.htm", "guidislink": false}